Department of Respiratory and Critical Care Medicine, Clinical Microbiology and Infectious Disease Lab, China-Japan Friendship Hospital, Beijing, 100029, China.
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Respir Res. 2020 Jul 7;21(1):173. doi: 10.1186/s12931-020-01424-x.
The European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria are widely used in the diagnosis of invasive pulmonary aspergillosis (IPA), but they only apply to immunocompromised patients. We here aimed to identify clinical characteristics helpful to the diagnosis of IPA in non-immunocompromised patients.
This is a multicenter retrospective study. Data were collected from adult patients with IPA admitted to 15 tertiary hospitals in China from 2010 to 2016.
We included 254 patients in the study, of whom 66 (26.0%) were immunocompromised, and 188 (74.0%) were not. Airway-invasion-associated computed tomography (CT) signs including patchy exudation along the airway (67.6% vs. 45.5%, P = 0.001) and thickened airway wall (42.0% vs. 16.7%, P < 0.001) were more common in non-immunocompromised patients than in immunocompromised ones, and angio-invasive CT signs were more common in immunocompromised patients (55.3% vs.72.7%, P = 0.013). Typical angio-invasive CT signs were delayed in non-immunocompromised IPA patients, whereas airway-invasive signs appear earlier. Host immunocompromised condition was associated with ICU admission and/or intubation (OR 1.095; 95% CI 1.461-6.122; P = 0.003). Poor prognosis (35.5% vs. 21.1%, P = 0.005) was more common in immunocompromised patients.
Airway-invasion-associated CT presentations at early stages of the disease are characteristic of IPA in non-immunocompromised hosts.
欧洲癌症研究与治疗组织/霉菌病研究组(EORTC/MSG)标准广泛应用于侵袭性肺曲霉病(IPA)的诊断,但仅适用于免疫功能低下的患者。我们旨在确定有助于非免疫功能低下患者 IPA 诊断的临床特征。
这是一项多中心回顾性研究。数据来自于 2010 年至 2016 年期间,在中国 15 家三级医院住院的 IPA 成人患者。
我们共纳入了 254 名患者,其中 66 名(26.0%)为免疫功能低下,188 名(74.0%)为非免疫功能低下。非免疫功能低下患者的气道侵袭相关 CT 征象包括沿气道分布的斑片状渗出(67.6% vs. 45.5%,P=0.001)和气道壁增厚(42.0% vs. 16.7%,P<0.001)更为常见,而免疫功能低下患者的血管侵袭性 CT 征象更为常见(55.3% vs. 72.7%,P=0.013)。非免疫功能低下 IPA 患者的典型血管侵袭性 CT 征象出现较晚,而气道侵袭性征象出现较早。宿主免疫功能低下与 ICU 入住和/或插管有关(OR 1.095;95%CI 1.461-6.122;P=0.003)。免疫功能低下患者的预后较差(35.5% vs. 21.1%,P=0.005)。
疾病早期的气道侵袭相关 CT 表现是非免疫功能低下宿主 IPA 的特征。